Jones Ryan Alexander 4
4 · Kyverna Therapeutics, Inc. · Filed Apr 15, 2025
Insider Transaction Report
Form 4
Jones Ryan Alexander
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2024-04-11+74,000→ 74,000 totalExercise: $2.06Exp: 2035-04-11→ Common Stock (74,000 underlying) - Award
Common Stock
2025-04-11+12,000→ 55,950 total
Footnotes (2)
- [F1]Represents a restricted stock unit award of common stock, 1/4th of which shall vest on April 11, 2026, and 1/4th of which shall vest on each one-year anniversary thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
- [F2]1/4th of the shares subject to the option shall vest on April 11, 2026, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.